A new Yale study says that a partnership with the Dollar General retail chain, which is being considered by the CDC, could bring vaccination sites substantially closer to low-income, Black, and Hispanic households in many parts of the United States.
Pfizer’s announcement that its experimental COVID-19 vaccine appears to be more than 90% effective has provided hope for relief from the increasingly calamitous onslaught of the virus. We asked Yale SOM’s Dr. Howard Forman about next steps.
Dr. Suzanne Lagarde ’14 describes how her federally qualified nonprofit health center is both adapting and expanding to meet new needs in an underserved community.
Earlier this year, a team of Yale researchers showed that the concentration of COVID-19 RNA in sewage mirrors the spread of the disease through a population. In a new study, they find that testing sewage can serve as an early indicator of an outbreak relative to hospitalizations.
Efforts in the late 1960s to desegregate hospitals in the American South did not significantly contribute to improvements in the Black infant mortality rate, finds a new study co-authored by Dean Kerwin Charles.
Epidemiological models have played an influential role in governments’ responses to the COVID-19 pandemic. Yale SOM’s Edieal Pinker takes a look back at one of the most influential models and argues that such rigorous efforts at understanding the likely course of the disease, while imperfect, are critical to good decision making.
We talked to Dr. Marcella Nunez-Smith, a Yale internist and an expert on the structural barriers to equitable treatment and health outcomes for people of color and other vulnerable populations.
Dr. Frank Ciminiello ’19 explains how his medical practice has reconfigured to safely meet patients’ needs.
In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Yale SOM’s Jason Abaluck and his co-authors calculated that the Medicare Advantage plans appreciably influence the survival rates of their enrollees. Shutting down the plans with the highest mortality rates could save thousands of lives per year.
David Browning ’99 explains how a nonprofit doing coffee sustainability verification became a source of crucial public health data.